
Information Technology · IT Consulting & Other Services
$232.50
+0.66%
Vol: 2.7M
Friday, May 1, 2026
IBM introduced Bob, an AI development platform automating enterprise software lifecycle (planning to modernization), with 80,000+ internal users reporting average 45% productivity gains. The company announced 750 new jobs at its Chicago quantum park. Q1 2026 showed 6% revenue growth, 13% free cash flow increase, and double-digit software gains. IBM's 2025 revenue was $67.54B (+7.62% YoY) with earnings up 75.88% to $10.59B. HSBC upgraded to Hold from Reduce with $231 PT, though stock declined 8.56% weekly.
IBM announced global general availability of Bob, its AI development partner, on April 28, 2026, with 80K+ internal users reporting average 45% productivity gains. Bob uses mix of frontier LLMs, open-source models, SLMs, and IBM's Granite SLM family to automate full software development lifecycle. Pricing: Pro $20/month (40 Bobcoins), Ultra $200/month (500 Bobcoins). IBM submitted proposal to Town of Poughkeepsie for new 511K sq ft quantum facility, expanding campus footprint to ~3.9M sq ft and creating 200 permanent jobs. IBM Quantum Starling (2029 release) targets fault-tolerant system with 100M quantum gates on 200 logical qubits. Q1 2026: revenue growth 6% (strongest first quarter in 10+ years), software revenue +8% (guidance +10% for 2026), free cash flow +13% YoY to $2.2B. Stock down 29% from all-time highs but up 1.6% post-Bob announcement. Analyst consensus: $296.95 PT, 10 Strong Buy / 2 Buy / 9 Hold / 1 Sell.
IBM reported Q1 2026 revenue of $15.9B (beat $15.7B estimate, up 9%), software revenue grew 11% to $7.05B. Free cash flow rose 13% YoY to $2.2B (highest Q1 in decade). IBM announcing 750 jobs in AI, quantum computing, cybersecurity over 5 years at Illinois Quantum and Microelectronics Park Chicago; $19M state tax credits. WatsonX now profitable; generative AI book of business crossed $12.5B. Guidance: 5%+ revenue growth 2026, software growth >10%, data revenue low 20s%. IBM Bob (AI development platform) launched. HSBC upgraded to Hold (from Reduce) with $231 PT.
IBM secured significant FedRAMP authorization on April 1 for 11 watsonx and automation tools, quadrupling its compliant solutions for US federal agencies. The company announced new cybersecurity measures on April 15 to help enterprises combat agentic attacks. IBM settled a $17 million DOJ probe into diversity and inclusion practices. The stock is down 22% YTD but Citi initiated coverage with a Buy rating and $285 price target, citing IBM AI deployment capabilities. Q1 2026 earnings due April 22.
IBM stock fallen nearly 22% in 2026 YTD. Citi initiated Buy with $285 target citing IBM track record of adapting to technology shifts. IBM expanded AI, quantum, and hardware collaborations. Company settled $17 million DEI probe. Stifel reduced target to $290 from $340 while maintaining Buy. 2025 revenue was $67.54 billion, up 7.62% YoY.
Citigroup initiated Buy with $285 PT on April 10. Q1 results April 22. Confluent acquisition contributing $50M Q1 revenue. Stock down ~22% YTD.
IBM will report Q1 earnings April 22 after market close. Needham trimmed price target by 14.7% ahead of results citing geopolitical and FX headwinds. Company expects 5%+ FY2026 revenue growth, generative AI book exceeds $12.5B, quantum computer on track for 2029 delivery.
IBM stock declined 2.23% to $236.35 with persistent selling pressure. Stifel lowered price target from $340 to $290. Stock trading below 20-day, 50-day, and 200-day moving averages. Q1 2026 results on April 20 with earnings call April 22 at 5 p.m. ET. Recent collaborations with Arm and Shared AI License Foundation.
IBM earnings estimates rising with 2026 EPS forecast up 6.6% to $12.44 and 2027 up 5.4% to $13.36. Company completed Confluent acquisition and expanded NVIDIA collaboration at GTC 2026. Tata Play Fiber announced watsonx AI platform adoption. April 22 earnings release viewed as key test of IBM's AI growth story. Focus on hybrid cloud, AI, and quantum partnerships.
IBM and Arm announced strategic partnership April 2 for dual-architecture hardware supporting enterprise AI. IBM Q1 2026 EPS came in at $4.52 vs expected $4.33. IBM secured FedRAMP approval for 11 AI and automation offerings. Stock closed at $246.74 on April 6. 13 Buy analysts with average target $332.94 (37% upside).
IBM announced FedRAMP approval for 11 AI and automation tools from its watsonx lineup for U.S. government use. The company completed Confluent acquisition in March and signed strategic R&D deal with ETH Zurich for 10-year AI and quantum algorithm collaboration. IBM published quantum-centric supercomputing reference architecture on March 12. Hiring plans include tripling entry-level US positions in 2026. Q1 2026 earnings scheduled for April 22. Earnings estimates raised 6.6% to $12.44.
IBM received FedRAMP authorization for 11 AI and automation solutions (including watsonx) through AWS GovCloud partnership. Strategic collaboration with ETH Zurich for AI/quantum algorithms (March 31). Partnership with Arm Holdings for dual-architecture hardware. Moderate Buy with $332.94 target.
IBM announced FedRAMP approval for 11 of its AI and automation tools through AWS GovCloud, meeting strict security and compliance standards for government use. The company also announced strategic collaborations with Arm and ETH Zurich. IBM shares rose 1.9% on the approval news. However, the stock is down 21% over the past 3 months, trading near $243 with analyst consensus of Moderate Buy and average price target of $332.94.
IBM completed Confluent acquisition March 17 for $31/share ($11 billion enterprise value), integrating real-time data streaming with watsonx.data platform. Announced expanded NVIDIA collaboration on March 16 for enterprise AI analytics. Quantum computer achieved significant breakthrough simulating real magnetic materials. Plans Blue Jay system with 2,000+ qubits. Q4 2025 EPS of $0.15 beat $0.04 estimates by 275%. Mean analyst PT $313.90, 29.9% upside.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| IBMINTL | $232.50 | +0.66% | -6.4% | 17.2x | 0.69 | $217.1B |
| ACNACCENTURE | $179.70 | +0.55% | -10.2% | 12.0x | 1.24 | $110.0B |
| CTSHCOGNIZANT | $52.48 | -0.80% | -15.2% | 8.6x | 0.98 | $25.0B |
| ITGARTNER | $146.63 | -1.25% | -4.7% | 10.1x | 1.04 | $10.0B |
| EPAMEPAM | $112.25 | -1.34% | -17.0% | 8.2x | 1.73 | $6.0B |
| NVDANVIDIA | $198.66 | -0.46% | +12.3% | 17.8x | 2.33 | $4.85T |
Price below 200d MA — bearish structure.